Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry

Duke University

Status: Enrolling

Conditions: Metastatic Cancer; Oligometastasis

Study type: Observational

Funder types: Other

Identifiers

NCT04085029

Pro00103137

Details and patient eligibility

About

The purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years of age
• Radiographic evidence of metastatic disease (may include oligoprogression, oligorecurrence or oligometastasis) at the time of study enrollment
• Planned to receive, currently receiving, or have completed hypofractionated image guided radiotherapy (ablative radiotherapy) to an extracranial site(s)
• Patient must sign study-specific informed consent

Exclusion criteria

• None